Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Leveraging preclinical models for the development of Alzheimer disease therapeutics.

Nature reviews. Drug discovery - 1 Jul 2020

Scearce-Levie Kimberly, Sanchez Pascal E, Lewcock Joseph W

Abstract excerpt

A large number of mouse models have been engineered, characterized and used to advance biomedical research in Alzheimer disease (AD). Early models simply damaged the rodent brain through toxins or lesions. Later, the spread of genetic engineering technology enabled investigators to develop models of familial AD by overexpressing human genes such as those encoding amyloid precursor protein (APP) or presenilins...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Biomarkers
Share to Disease Models, Animal

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Development

Share to Drug Evaluation, Preclinical

Share to Genetic Predisposition to Disease

Share to Risk Factors

Source

Identifiers

PMID: 32612262
DOI: 10.1038/s41573-020-0065-9

Genes

APP
PSEN1
PSEN2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Leveraging preclinical models for the development of Alzheimer disease therapeutics.PMID 32612262Read ↗

Mouse models of Alzheimer's disease for preclinical research.Semantic proximity Read ↗

Insights on the Use of Transgenic Mice Models in Alzheimer’s Disease ResearchSemantic proximity Read ↗

A Review of the Current Mammalian Models of Alzheimer's Disease and Challenges That Need to Be Overcome.Semantic proximity Read ↗

The importance of continuing development of novel animal models of Alzheimer's disease and Alzheimer's disease and related dementiasSemantic proximity Read ↗

Beyond Transgenic Mice: Emerging Models and Translational Strategies in Alzheimer’s DiseaseSemantic proximity Read ↗

Animal and Cellular Models of Alzheimer’s Disease: Progress, Promise, and Future ApproachesSemantic proximity Read ↗

Mammalian Models in Alzheimer's Research: An updateSemantic proximity Read ↗

Transgenic Mouse Models of Alzheimer’s Disease: An Integrative AnalysisSemantic proximity Read ↗

Rodent models for Alzheimer’s disease drug discoverySemantic proximity Read ↗

Transgenic Mouse Models of Alzheimer Disease: Developing a Better Model as a Tool for Therapeutic InterventionsSemantic proximity Read ↗

Transgenic mouse models of Alzheimer's disease.Semantic proximity Read ↗

Overview of Transgenic Mouse Models for Alzheimer's DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.